Clinical trial
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
NCT00068419 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00068419 |
|---|---|
| Title | Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor |
| Official title | A Phase II Study of Sulindac and Tamoxifen in Patients With Desmoid Tumors That Are Recurrent or Not Amenable to Standard Therapy |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Desmoid Tumor |
| Intervention type | Drug, Other |
| Interventions | tamoxifen citrate, sulindac, laboratory biomarker analysis |
| Enrollment | 70 |
| Start date | Feb 1, 2004 |
| Primary completion | Apr 26, 2010 |
| Completion | Apr 26, 2010 |
| First posted | Sep 11, 2003 |
| Last update posted | Feb 19, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: